Winshine Science Company Limited (stock code: 00209) published its Monthly Return for the period ended 31 October 2025. According to the announcement, the issuer maintained an authorized share capital of 70,000,000,000 ordinary shares at a par value of HKD 0.01, totaling HKD 700,000,000. No changes were recorded in the authorized or issued share capital during the reporting month, with the number of issued shares remaining at 185,708,976.

In the share option scheme, there were no new shares issued under outstanding options, while 14,535,748 shares could potentially be issued if share options are granted under the scheme. The company also announced a proposed rights issue on the basis of seven rights shares for every one existing share at a subscription price of HKD 0.14 per rights share. This proposal, aiming to raise up to approximately HKD 182 million through the potential issuance of up to 1,299,962,832 rights shares, is subject to shareholders’ approval at a special general meeting scheduled for 5 December 2025.

No other relevant movements or changes in treasury shares were reported.